Medication adherence in hyperlipidemia remains poor on a nationally representative level. Predictors of medication adherence from a nationally representative commercial health plan are reported.
Phillip Wiegand, PharmD, MS
Advertisement
Articles by Phillip Wiegand, PharmD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
Home-Based Heart Failure Care Shows Comparable Safety to Continued Inpatient Care
3
Voice Biomarkers Show Promise for Asthma, COPD Exacerbation Detection
4
Cardiology Prices Vary Widely by Insurer and State
5